Iqvia Holdings Inc. (IQV) Stock Price & Analysis
Iqvia Holdings Inc. (IQV) fell 1.42% to USD 267.77 as of September 8, 2026 at 02:50 UTC, according to Nexqual real-time market data.
IQV last closed at USD 267.77; the session ranged USD 262.6–271.8 on volume of 1,183,743 shares. Market capitalization is —, with a 52-week range of USD 154.5–271.8 (NYQ). Source: Nexqual, September 8, 2026 at 02:50 UTC.
Key Statistics (as of September 8, 2026 at 02:50 UTC)
| Price | USD 267.77 |
|---|---|
| Change | ▼ 1.42% (down) |
| Previous Close | USD 267.77 |
| Open | USD 267.77 |
| Day Range | USD 262.6 – 271.8 |
| 52-Week Range | USD 154.5 – 271.8 |
| Volume | 1,183,743 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (IQV)
Nexqual's technical model rates IQV "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 02:50 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.23 (overbought) |
| vs SMA50 | Above (USD 230.13) |
| MACD | 10.97 (positive) |
From Iqvia Holdings Inc.'s Latest SEC 10-K Filing (filed 2026-02-17)
Key Strengths & Strategy (as disclosed to the SEC)
- Our scaled and growing information set contains approximately 68 petabytes of unique proprietary data sourced from approximately 150,000 data suppliers and covering over one million data feeds globally.
- We combine our proprietary information assets with advanced analytics, transformative technology and domain expertise to develop clinical and commercial capabilities that enable us to grow our relationships with healthcare stakeholders throughout the life science's value chain.
- Second, the addressable opportunity for connected healthcare is approximately $55 billion, and includes areas such as revenue cycle management, payer & provider analytics and clinical decision support services. • Technology enabled commercial operations: Total addressable market of approximately $84 billion in 2025 that includes information, data warehousing, IT outsourcing, software applications and other services in the broader market for IT services.
- Beyond our proprietary information assets, we have developed key capabilities to assess opportunities to develop and commercialize therapies, support and defend the value of medicines and help our clients operate more efficiently through the application of our clinical, scientific and operational knowledge as well as our insight-driven decision-making and cost-efficient technology solutions.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MTD | Mettler-Toledo International, I | USD 1,345.26 | ▼ 1.64% |
| FTV | Fortive Corporation | USD 56.94 | ▲ 0.6% |
| COO | The Cooper Companies, Inc. | USD 69.59 | ▼ 0.2% |
| TFX | Teleflex Incorporated | USD 138.36 | ▼ 1.85% |
| CRL | Charles River Laboratories Inte | USD 288.5 | ▼ 1.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:50 UTC. This page is informational and not investment advice.